SUBSCRIBE
SUBSCRIBE

Search Results

862,961 Results
Type
Multimedia
Section
Tag
Date
Location
There are 862,961 results that match your search.
  • Helicore
    Helicore Biopharma, Inc., is a clinic-ready multi-product biopharmaceutical company focused on the discovery and development of novel weight-loss therapeutics.
  • Press Releases
    SonoThera Presents New Data at ASN Kidney Week 2025
    November 5, 2025
     · 
    1 min read
  • Granite Bio
    Targeting fundamentals of inflammation, autoimmunity and fibrosis
  • Dispatch Bio
    Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform.
  • Coursera Health
  • Aggressive obstacle from the boss. Concept illustration. Vector illustration
    Obesity
    Is Metsera Worth The Fuss?
    Pfizer and Novo Nordisk seem to want Metsera bad. Analysts are wondering, though: is the obesity biotech really worth this much effort?
    November 5, 2025
     · 
    4 min read
     · 
    Annalee Armstrong
  • FDA Headquarters_Grandbrothers/Adobe Stock
    Rare diseases
    FDA Overruled Reviewers in Approving Stealth’s Barth Syndrome Treatment
    According to reporting from Reuters, reviewers at the agency pointed to an inability to differentiate from placebo to justify rejecting the drug, but an FDA office director approved the drug anyway.
    November 5, 2025
     · 
    2 min read
     · 
    Dan Samorodnitsky
  • City Therapeutics
    Founded by pioneering executives and scientists in RNAi, City Therapeutics is advancing next-generation engineering of small interfering RNAs (siRNAs) – the “trigger” molecules that mediate RNAi – to improve and expand the reach of RNAi-based medicines.
  • Blue Earth Therapeutics
    Blue Earth Therapeutics is a clinical stage radiopharmaceutical company dedicated to the advancement of next generation targeted radiotherapeutics to treat cancer patients.
  • Bambusa Therapeutics
    Bambusa Therapeutics is a clinical-stage biotechnology company that uses an innovative antibody engineering platform to develop next-generation bispecific antibodies for treating a wide range of immunological and inflammatory disorders.